Spontaneous fibroblast-derived pericyte recruitment in a human tissue-engineered angiogenesis model in vitro

Journal of Cellular Physiology

Volumn 227, Issue 5, 2012, Pages 2130-2137

  Berthod, François ^a   Symes, Julie ^b   Tremblay, Nathalie ^a   Medin, Jeffrey A ^b,c   Auger, François A ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIMETHOXY 2 PHENYLQUINOXALINE; CD31 ANTIGEN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SMOOTH MUSCLE ACTIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CAPILLARY LIKE TUBE; CELL MATURATION; CONNECTIVE TISSUE; CONTROLLED STUDY; ENDOTHELIALIZED RECONSTRUCTED CONNECTIVE TISSUE; ENDOTHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROVASCULAR ENDOTHELIAL CELL; PERICYTE; PRIORITY JOURNAL; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL;

ACTINS; ANTIGENS, CD31; CAPILLARIES; CELL CULTURE TECHNIQUES; FIBROBLASTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFANT, NEWBORN; MODELS, CARDIOVASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PERICYTES; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TISSUE ENGINEERING; VON WILLEBRAND FACTOR;

EID: 84856170502     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22943     Document Type: Article

References (41)

1. Armulik A, Abramsson A, Betsholtz C. 2005. Endothelial/pericyte interactions. Circ Res 97: 512-523.
2. Baluk P, Hashizume H, McDonald DM. 2005. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15: 102-111.
3. Berthod F, Germain L, Tremblay N, Auger FA. 2006. Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. J Cell Physiol 207: 491-498.
4. Berthod F, Germain L, Pouliot R, Auger F. 2010. How to achieve early vascularization of tissue-engineered skin substitutes. In: Sen CK, editor. Advances in wound care. New Rochelle, NY: Mary Ann Liebert, Inc. p 445-450.
5. Black A, Berthod F, L'Heureux N, Germain L, Auger FA. 1998. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J 12: 1331-1340.
6. Cai X, Lin Y, Friedrich CC, Neville C, Pomerantseva I, Sundback CA, Zhang Z, Vacanti JP, Hauschka PV, Grottkau BE. 2009. Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev 5: 437-445.
7. Caplan AI. 2008. All MSCs are pericytes? Cell Stem Cell 3: 229-230.
8. Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, Dijke PT, Arthur HM, Mummery CL. 2004. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: A paradigm for hereditary haemorrhagic telangiectasia. Development 131: 6237-6247.
9. Crisan M, Deasy B, Gavina M, Zheng B, Huard J, Lazzari L, Peault B. 2008a. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: Myoendothelial cells and pericytes. Methods Cell Biol 86: 295-309.
10. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Peault B. 2008b. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313.
11. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B. 2009. Perivascular multipotent progenitor cells in human organs. Ann NY Acad Sci 1176: 118-123.
12. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-de Groot AC. 1997. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 80: 444-451.
13. Dore-Duffy P, Katychev A, Wang X, Van Buren E. 2006. CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab 26: 613-624.
14. Dreyfus PA, Chretien F, Chazaud B, Kirova Y, Caramelle P, Garcia L, Butler-Browne G, Gherardi RK. 2004. Adult bone marrow-derived stem cells in muscle connective tissue and satellite cell niches. Am J Pathol 164: 773-779.
15. Fukushi J, Makagiansar IT, Stallcup WB. 2004. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell 15: 3580-3590.
16. Gushi A, Tanaka M, Tsuyama S, Nagai T, Kanzaki T, Kanekura T, Matsuyama T. 2008. The 3G5 antigen is expressed in dermal mast cells but not pericytes. J Cutan Pathol 35: 278-284.
17. Hagedorn M, Balke M, Schmidt A, Bloch W, Kurz H, Javerzat S, Rousseau B, Wilting J, Bikfalvi A. 2004. VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis. Dev Dyn 230: 23-33.
18. Haralabopoulos GC, Grant DS, Kleinman HK, Maragoudakis ME. 1997. Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Am J Physiol 273: C239-245.
19. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126: 3047-3055.
20. Huang FJ, You WK, Bonaldo P, Seyfried TN, Pasquale EB, Stallcup WB. 2010. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. Dev Biol 344: 1035-1046.
21. Hudon V, Berthod F, Black AF, Damour O, Germain L, Auger FA. 2003. A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br J Dermatol 148: 1094-1104.
22. Kolb M, Margetts PJ, Sime PJ, Gauldie J. 2001. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280: L1327-1334.
23. Kovalenko M, Ronnstrand L, Heldin CH, Loubtchenkov M, Gazit A, Levitzki A, Bohmer FD. 1997. Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296. Biochemistry 36: 6260-6269.
24. Kurz H, Fehr J, Nitschke R, Burkhardt H. 2008. Pericytes in the mature chorioallantoic membrane capillary plexus contain desmin and alpha-smooth muscle actin: Relevance for non-sprouting angiogenesis. Histochem Cell Biol 130: 1027-1040.
25. Lamagna C, Bergers G. 2006. The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 80: 677-681.
26. Lindahl P, Johansson BR, Leveen P, Betsholtz C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
27. McCarty MF, Somcio RJ, Stoeltzing O, Wey J, Fan F, Liu W, Bucana C, Ellis LM. 2007. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. J Clin Invest 117: 2114-2122.
28. Moulin V, Auger FA, O'Connor-McCourt M, Germain L. 1997. Fetal and postnatal sera differentially modulate human dermal fibroblast phenotypic and functional features in vitro. J Cell Physiol 171: 1-10.
29. Orlidge A, D'Amore PA. 1987. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105: 1455-1462.
30. Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE, McDonald DM, Blau HM. 2004. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113: 516-527.
31. Ozerdem U, Stallcup WB. 2004. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis 7: 269-276.
32. Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB. 2001. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 222: 218-227.
33. Paquet-Fifield S, Schluter H, Li A, Aitken T, Gangatirkar P, Blashki D, Koelmeyer R, Pouliot N, Palatsides M, Ellis S, Brouard N, Zannettino A, Saunders N, Thompson N, Li J, Kaur P. 2009. A role for pericytes as microenvironmental regulators of human skin tissue regeneration. J Clin Invest 119: 2795-2806.
34. Parenteau-Bareil R, Gauvin R, Cliche S, Gariépy C, Germain L, Berthod F. 2011. Comparative study of bovine, porcine and avian Collagens for the production of a tissue-engineered dermis. Acta Biomater DOI: 10.1016/j.actbio.2011.06.020.
35. Raza A, Franklin MJ, Dudek AZ. 2010. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 85: 593-598.
36. Reinmuth N, Liu W, Jung YD, Ahmad SA, Shaheen RM, Fan F, Bucana CD, McMahon G, Gallick GE, Ellis LM. 2001. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15: 1239-1241.
37. Sato T, Neschadim A, Konrad M, Fowler DH, Lavie A, Medin JA. 2007. Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. Mol Ther 15: 962-970.
38. Shepro D, Morel NM. 1993. Pericyte physiology. FASEB J 7: 1031-1038.
39. Tremblay PL, Berthod F, Germain L, Auger FA. 2005a. In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue. J Pharmacol Exp Ther 315: 510-516.
40. Tremblay PL, Hudon V, Berthod F, Germain L, Auger FA. 2005b. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 5: 1002-1010.
41. Yoshimitsu M, Sato T, Tao K, Walia JS, Rasaiah VI, Sleep GT, Murray GJ, Poeppl AG, Underwood J, West L, Brady RO, Medin JA. 2004. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc Natl Acad Sci USA 101: 16909-16914.